Showing results (321-330 of 391) with videos related to
Sort By:
Pageof 40
Annals of Surgical Oncology|September 13, 2020
Prospective Multicenter Study Validate a Prediction Model for Surgery Uptake Among Women with Atypical Breast LesionsCatherine Uzan, Chafika Mazouni, Caroline Rossoni, et al.Analytical Chemistry|April 13, 2022
Real-Time Detection of ESR1 Mutation in Blood by Droplet Digital PCR in the PADA-1 Trial: Feasibility and Cross-Validation with NGSCeline Callens, Francois-Clement Bidard, Anaïs Curto-Taribo, et al.Nature Communications|June 22, 2023
Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trialManuel Rodrigues, Giulia Vanoni, Pierre Loap, et al.The American Journal of Surgical Pathology|May 5, 2021
Infantile Rhabdomyosarcomas With VGLL2 Rearrangement Are Not Always an Indolent Disease: A Study of 4 Aggressive Cases With Clinical, Pathologic, Molecular, and Radiologic FindingsJoanna Cyrta, Arnaud Gauthier, Marie Karanian, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2018
Capecitabine Efficacy Is Correlated with TYMP and RB1 Expression in PDX Established from Triple-Negative Breast CancersElisabetta Marangoni, Cécile Laurent, Florence Coussy, et al.Molecular Oncology|August 5, 2020
Fine-needle aspiration as an alternative to core needle biopsy for tumour molecular profiling in precision oncology: prospective comparative study of next-generation sequencing in cancer patients included in the SHIVA02 trialCélia Dupain, Julien Masliah-Planchon, Céline Gu, et al.The American Journal of Surgical Pathology|July 6, 2018
The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for TreatmentCaterina Marchiò, Patrizia Dell'Orto, Laura Annaratone, et al.The Journal of Pathology|June 23, 2015
Genomic landscape of adenoid cystic carcinoma of the breastLuciano G Martelotto, Maria R De Filippo, Charlotte K Y Ng, et al.Iscience|March 19, 2026
CMV seropositivity associates with poor clinical outcome in triple negative breast cancerRomain-David Seban, Constance Lamy, Luc Cabel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2025
Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: Development and Validation of a Clinicopathologic AssayFrançois-Clément Bidard, Grégoire Gessain, Thomas Bachelot, et al.Pageof 40